The race to find a vaccine for the Coronavirus has taken conversations about the speed of clinical trials out of laboratories and into living rooms while testing of drugs that would have taken decades to complete now compressed down into years and even months.
There have never been a set of clinical trials that have had so much investment and political focus but what does this surge in clinical trial activity mean for research into neurological illnesses, such as Motor Neurone Disease and Alzheimers, which lag behind those aimed at cancer treatments?
Could the acceleration of clinical testing due to the Coronavirus lead to advances in treatments for neurological conditions?
Leigh Fell of Caritas Neuro believes it could.
To read the full article on The Scotsman website: https://www.scotsman.com/health/could-mnd-and-alzheimers-cures-be-closer-due-coronavirus-clinical-trials-2866831